Authors: SZAMEL I HINDY I BUDAI B KANGAS L HAJBA A LAMMINTAUSTA R

Citation: I. Szamel et al., ENDOCRINE MECHANISM OF ACTION OF TOREMIFENE AT THE LEVEL OF THE CENTRAL-NERVOUS-SYSTEM IN ADVANCED BREAST-CANCER PATIENTS, Cancer chemotherapy and pharmacology, 42(3), 1998, pp. 241-246

Authors: SZAMEL I HINDY I BUDAI B KANGAS L HAJBA A LAMMINTAUSTA R

Citation: I. Szamel et al., ENDOCRINE EFFECTS OF TOREMIFENE (TOR) AT THE LEVEL OF CNS IN ADVANCEDBREAST-CANCER PATIENTS, European journal of cancer, 33, 1997, pp. 683-683

Authors: SZAMEL I HINDY I BUDAI B KANGAS L HAJBA A LAMMINTAUSTA R

Citation: I. Szamel et al., LHRH AGONIST ANALOG FUNCTIONAL TEST IN ADVANCED BREAST-CANCER PATIENTS TREATED WITH TOREMIFENE(TOR), European journal of cancer, 31A, 1995, pp. 371-371

Authors: SZAMEL I BUDAI B DAUBNER K KRALOVANSZKY J OTTO S TOTH J BESZNYAK I

Citation: I. Szamel et al., HORMONAL CHARACTERIZATION AND CLASSIFICATION OF BREAST CYST FLUID IN GROSS CYSTIC MASTOPATHY, Endocrine-related cancer, 1(2), 1994, pp. 49-55